POM Shot Down Again by FTC

Company intends to appeal

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

POM Wonderful just got some not-so-wonderful news. The maker of pomegranate juice and supplements once again has been slapped down by the Federal Trade Commission for deceptively advertising that POM products were clinically proven to treat, prevent or reduce the risk of heart disease, prostate cancer and erectile dysfunction.

In a unanimous decision, the FTC today upheld the opinion of chief administrative law Judge Michael Chappell who found in May that POM's ads in publications such as Parade, Fitness and The New York Times made unsupportive health claims.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Spring Special

Save 30% Off an ADWEEK Subscription Today!

View Your Options

Already a member? Sign in